Shares of Moderna Inc. /zigman2/quotes/205619834/composite MRNA -0.55% shed 5.06% to $150.00 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index /zigman2/quotes/210598365/realtime COMP -1.80% rising 0.21% to 12,965.34 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA -1.62% rising 0.06% to 33,999.04. This was the stock's third consecutive day of losses. Moderna Inc. closed $314.85 short of its 52-week high ($464.85), which the company achieved on September 10th.
The stock underperformed when compared to some of its competitors Thursday, as AbbVie Inc. /zigman2/quotes/202428675/composite ABBV +0.03% fell 0.11% to $141.29, Amgen Inc. /zigman2/quotes/209157011/composite AMGN -0.34% fell 0.35% to $249.70, and AstraZeneca PLC ADR /zigman2/quotes/200304487/composite AZN -3.07% rose 0.12% to $66.50. Trading volume (7.0 M) eclipsed its 50-day average volume of 5.1 M.